Semi-supervised learning has been gaining attention as it allows for performing image analysis tasks such as classification with limited labeled data. Some popular algorithms using Generative Adversarial Networks (GANs) for semi-supervised classification share a single architecture for classification and discrimination. However, this may require a model to converge to a separate data distribution for each task, which may reduce overall performance. While progress in semi-supervised learning has been made, less addressed are small-scale, fully-supervised tasks where even unlabeled data is unavailable and unattainable. We therefore, propose a novel GAN model namely External Classifier GAN (EC-GAN), that utilizes GANs and semi-supervised algorithms to improve classification in fully-supervised regimes. Our method leverages a GAN to generate artificial data used to supplement supervised classification. More specifically, we attach an external classifier, hence the name EC-GAN, to the GAN’s generator, as opposed to sharing an architecture with the discriminator. Our experiments demonstrate that EC-GAN's performance is comparable to the shared architecture method, far superior to the standard data augmentation and regularization-based approach, and effective on a small, realistic dataset.
Early detection of suicidal ideation in depressed individuals can allow for adequate medical attention and support, which in many cases is life-saving. Recent NLP research focuses on classifying, from a given piece of text, if an individual is suicidal or clinically healthy. However, there have been no major attempts to differentiate between depression and suicidal ideation, which is an important clinical challenge. Due to the scarce availability of EHR data, suicide notes, or other similar verified sources, web query data has emerged as a promising alternative. Online sources, such as Reddit, allow for anonymity that prompts honest disclosure of symptoms, making it a plausible source even in a clinical setting. However, these online datasets also result in lower performance, which can be attributed to the inherent noise in web-scraped labels, which necessitates a noiseremoval process. Thus, we propose SDCNL, a suicide versus depression classification method through a deep learning approach. We utilize online content from Reddit to train our algorithm, and to verify and correct noisy labels, we propose a novel unsupervised label correction method which, unlike previous work, does not require prior noise distribution information. Our extensive experimentation with multiple deep word embedding models and classifiers display the strong performance of the method in a new, challenging classification application. We make our code and dataset available at https://github.com/ayaanzhaque/SDCNL
Diabetes is one of the most prevalent chronic diseases in Bangladesh, and as a result, Diabetic Retinopathy (DR) is widespread in the population. DR, an eye illness caused by diabetes, can lead to blindness if it is not identified and treated in its early stages. Unfortunately, diagnosis of DR requires medically trained professionals, but Bangladesh has limited specialists in comparison to its population. Moreover, the screening process is often expensive, prohibiting many from receiving timely and proper diagnosis. To address the problem, we introduce a deep learning algorithm which screens for different stages of DR. We use a state-of-the-art CNN architecture to diagnose patients based on retinal fundus imagery. This paper is an experimental evaluation of the algorithm we developed for DR diagnosis and screening specifically for Bangladeshi patients. We perform this validation study using separate pools of retinal image data of real patients from a hospital and field studies in Bangladesh. Our results show that the algorithm is effective at screening Bangladeshi eyes even when trained on a public dataset which is out of domain, and can accurately determine the stage of DR as well, achieving an overall accuracy of 92.27% and 93.02% on two validation sets of Bangladeshi eyes. The results confirm the ability of the algorithm to be used in real clinical settings and applications due to its high accuracy and classwise metrics. Our algorithm is implemented in the application Drishti, which is used to screen for DR in patients living in rural areas in Bangladesh, where access to professional screening is limited. 2
CT image quality is heavily reliant on radiation dose, which causes a trade-off between radiation dose and image quality that affects the subsequent image-based diagnostic performance. However, high radiation can be harmful to both patients and operators. Several (deep learning-based) approaches have been attempted to denoise low dose images. However, those approaches require access to large training sets, specifically the full dose CT images for reference, which can often be difficult to obtain. Self-supervised learning is an emerging alternative for lowering the reference data requirement facilitating unsupervised learning. Currently available self-supervised CT denoising works are either dependent on foreign domain or pretexts are not very task-relevant. To tackle the aforementioned challenges, we propose a novel self-supervised learning approach, namely Self-Supervised Window-Leveling for Image DeNoising (SSWL-IDN), leveraging an innovative, task-relevant, simple, yet effective surrogate-prediction of the window-leveled equivalent. SSWL-IDN leverages residual learning and a hybrid loss combining perceptual loss and MSE, all incorporated in a VAE framework. Our extensive (in-and cross-domain) experimentation demonstrates the effectiveness of SSWL-IDN in aggressive denoising of CT (abdomen and chest) images acquired at 5% dose level only. 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.